Cite
HARVARD Citation
Verdoia, M. et al. (2020). Vitamin D levels condition the outcome benefits of renin-angiotensin system inhibitors (RASI) among patients undergoing percutaneous coronary intervention. Pharmacological research. p. . [Online].